SMC Laboratories
Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.
9 contract research organizations in our directory list both Metabolic Disease Models and Mouse among their capabilities, across 6 countries. 1 reports GLP capability and 1 reports AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 9 CROs. Order rotates daily so no lab is permanently listed first.
Tokyo CRO known for NASH/MASH and fibrosis mouse models, with efficacy studies across liver, kidney and metabolic disease.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.
In vivo pharmacology CRO near Philadelphia running a broad catalog of efficacy models across CNS, pain, metabolic and inflammatory disease.
Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.
Preclinical CRO near Toulouse specializing in metabolic disease pharmacology, including obesity, diabetes and NASH/MASH models.
Nonprofit mouse genetics institute offering contract in vivo pharmacology using its own strains and humanized and PDX models across oncology, neuroscience, metabolism and immunology.
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.